Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe explicit 'Prostate cancer' label and the 'MedlinePlus Genetics' related topic linkage have been removed, along with the 'related topics' header. This changes how the study's subject is presented and which educational resources are shown to users.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page now features Prostate cancer as a related topic and MedlinePlus Genetics as a related topics resource, linking the study to disease-specific background information and educational materials.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing v3.5.3. This indicates a small system/template update and does not modify the study content or its outcomes.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted the related topics block that listed Prostate Cancer and MedlinePlus Genetics. The page will no longer display these related informational resources as part of the study record.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded Prostate cancer and a related topics section with a MedlinePlus Genetics link to broaden contextual resources, and updated the revision label from v3.5.2 to v3.5.3.SummaryDifference0.2%

- Check43 days agoChange DetectedRemoved the “Prostate cancer” related topics links, including the MedlinePlus Genetics section.SummaryDifference0.2%

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.